Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma

Fig. 2

Immunohistochemical analysis of HER1, HER2 and HER3 co-expression on three LSCCs. The left and middle columns in the panel show two poorly differentiated LSCCs (H&E in the boxes above) with phenotype HER1+/HER2+/HER3− and HER1+/HER2−/HER3−, respectively. In the right column a well differentiated LSCC (H&E in the top box) expressing the phenotype HER1+/HER2+/HER3+ (Original magnifications: H&E: 200×; HER1, HER2 and HER3: 400×)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us